Faculty

YU Yue

Ph.D. Supervisor, Deputy Director of the Department of Gastroenterology, and Director of the Gastrointestinal Disease Department at the First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital). Chief Physician, Professor, and Ph.D. Supervisor at the University of Science and Technology of China, Shandong University, and Anhui Medical University. Committee Member of the Gastrointestinal Functional Disease Collaboration Group of the Chinese Society of Gastroenterology, Member of the Integrated Chinese and Western Medicine Collaboration Group of the Chinese Society of Gastroenterology, Standing Committee Member of the Digestive Psychosomatic Health Professional Committee of the Western Psychiatry Association, Vice Chairman of the Chinese Integrated Chinese and Western Medicine Intestinal Disease Alliance, Deputy Director of the Anhui Provincial Committee of the Chinese Digestive Psychosomatic Alliance, Deputy Director of the Gastroenterology Professional Committee of the Anhui Provincial Society of Integrated Chinese and Western Medicine, Standing Committee Member of the Gastroenterology Physicians Branch of the Anhui Medical Doctor Association, and Head of the Gastrointestinal Motility and Functional Disease Group of the Gastroenterology Branch of the Anhui Medical Association. Editorial board member and reviewer for ten journals, including the *Chinese Journal of Behavioral Medicine and Brain Science* and the *Journal of Gastroenterology and Hepatology*.

 

Dr. Yu has been engaged in the basic and clinical scientific research of gastrointestinal motility disorders, digestive psychosomatic diseases, and pancreatic cancer for a long time, with a particular focus on the integrated treatment of gastrointestinal diseases using Chinese and Western medicine.

 

Education and Work Experience

- 19861991: Bachelors in Clinical Medicine, Xianning Medical College, Hubei

- 19941997: Masters in Internal Medicine (Gastroenterology), Tongji Medical College, Huazhong University of Science and Technology

- 20022005: Ph.D. in Internal Medicine (Gastroenterology), Tongji Medical College, Huazhong University of Science and Technology

- AugustNovember 2010: Visiting Scholar in Gastroenterology, Fürth Hospital (University Hospital Erlangen), Germany

- 19911994: Physician, Department of Gastroenterology, Fifth Hospital of Huangshi City, Hubei

- 19972002: Attending Physician, Affiliated Fifth Hospital of Hubei Polytechnic University Medical School

- 2005November 2017: Associate Chief Physician and Chief Physician, Anhui Provincial Hospital

- December 2017Present: Chief Physician, Department of Gastroenterology, First Affiliated Hospital of USTC

 

Academic Achievements and Impact

Dr. Yu has dedicated over 20 years to teaching and scientific research in gastroenterology and digestive endoscopy, mentoring over 40 Ph.D. and masters students. He has received the second prize of the Anhui Medical Science and Technology Award.

 

He has published over 130 research papers as the first or corresponding author in renowned international and domestic journals, including *Biomaterials*, *ACS Applied Materials & Interfaces*, *Biomaterials Science*, *Theranostics*, *Oncology Letters*, *Chinese Journal of Behavioral Medicine and Brain Science*, *Chinese Journal of Digestive Diseases*, *Chinese Journal of Integrated Traditional and Western Medicine*, and *Shizhen Traditional Chinese Medicine and Materia Medica*. Over 20 of these papers are indexed by SCI. He has also authored three monographs and contributed to four others.

 

Ongoing Projects (Principal Investigator Only)

1. Project Name: Research on Ultra-Fast Activated Cell-Penetrating Peptides Enhancing Nano-Drug Therapy for Pancreatic Cancer

   - Source: National Natural Science Foundation of China

   - Total Funding: 590,000 RMB

   - Duration: 2019-01 to 2022-12

 

2. Project Name: Application of Intelligent Nanomaterials in Early Diagnosis and Precision Treatment of Pancreatic Cancer

   - Source: Special Fund for Basic Scientific Research of Central Universities

   - Total Funding: 800,000 RMB

   - Duration: 2019-01 to 2021-12

 

Primary Research Areas (Graduate Programs) and Content

Clinical Medicine

 

1. Gastroenterology

   - Basic and clinical research on gastrointestinal motility disorders and functional gastrointestinal diseases

   - Early diagnosis and targeted therapy of gastrointestinal tumors (especially pancreatic cancer)

   - Techniques in digestive endoscopy


Representative Papers (Last Five Years)

1.  Liu J, Yin M, Lv C, Wang W, Huang Y, Tian J, Wang B, Song G, Yu Y*. Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict proton pump inhibitor response in patients with reflux hypersensitivity. J Gastroenterol Hepatol. 2024 Aug 8. doi: 10.1111/jgh.16718. Epub ahead of print. PMID: 39118430.

2.  Huang WQ, Zhu YQ, Gao F, You W, Chen G, Nie X, Xia L, Wang LH, Hong CY, Zhang Z, Wang F, Yu Y*, You YZ*. Nanogalvanic Cells Release Highly Reactive Electrons in Tumors to Effectively Eliminate Tumors. Adv Mater. 2024 Jul 1;36(30):e2404199. doi: 10.1002/adma.202404199. Epub 2024 May 20. PMID: 38734974.

3.  Liu J, Dai Q, Qu T, Ma J, Lv C, Wang H*, Yu Y*.Ameliorating effects of transcutaneous auricular vagus nerve stimulation on a mouse model of constipation-predominant irritable bowel syndrome. Neurobiol Dis. 2024 Feb 16 ;193 :106440. doi: 10.1016/j.nbd.2024.106440.

4.  Liu G, Liu M, Li X, Ye X, Cao K*Liu Y*, Yu Y*.Peroxide-Simulating and GSH-Depleting Nanozyme for Enhanced Chemodynamic/Photodynamic Therapy via Induction of Multisource ROS.ACS Appl Mater Interfaces. 2023 Oct 9. 2023-10-18;15(41):47955-47968.doi: 10.1021/acsami.3c09873.

5.  Liu XY# Chu ZY#Chen BJMa Y,Xu LL,  Qian HS* ,Yu Y*.Cancer cell membrane-coated upconversion nanoparticles/ZnxMn1-xS core-shell nanoparticles for targeted photodynamic and chemodynamic therapy of pancreatic cancer.Materials Today Bio, Aug 14 2023, 22:100765

6.Liu J# ,Fang HY#,Hong N,Lv CL,Zhu QH,Feng YP,Wang B,Tian JS,Yu Y*.Gut microbiome and metabonomic profile predict early remission to anti-integrin therapy in patients with moderate to severe ulcerative colitis.Microbiology Spectrum 2023 Jun 15;11(3):e0145723

7. Zhang C#, Li QR#, Shan J#, Xing JH,  Liu XY, Ma Y, Qian HS, Chen XL, Wang XW*,Wu LM*, Yu Y*.Multifunctional Two-Dimensional Bi2Se3 Nanodiscs for Anti-Inflammatory Therapy of Inflammatory Bowel Diseases.Acta Biomaterialia2023, 160: 252-264

8. Zhu YQ, Huang WQ, Chen G, Xia L,You YZ*,Yu Y,*. Sticking-bacteria gel enhancing anti-multidrug-resistant microbial therapy under ultrasound. Nano Research. 2022, 15 (10): 9105-9113.

9. Feng X, Yang K, Feng Z, Xie Y, Han W, Chen Q, Li S, Zhang Y, Yu Y*, Zou G*.Selective and sensitive detection of miRNA-198 using single polymeric microfiber waveguide platform with heterogeneous CHA amplification strategy..Talanta. 2022 Apr 1;240:123218. doi: 10.1016/j.talanta.2022.123218. Epub 2022 Jan 8.PMID: 35026632

10. Zhan X#, Nie X#, Gao F,  Zhang C,  You YZ*  and  Yu Y*  .NIR-activated polymeric nanoplatform with ROS- and temperature-sensitive for combined photothermal and chemotherapy on pancreatic cancer.Biomater Sci, 2020, 8(21), 5931 - 5940


Contact Information

E-mail: yuyuemd@ustc.edu.cn

Phone: 0551-62284093 / 62284225 / 18963788890